Soligenix, Inc. (SNGX) Social Stream
SOLIGENIX INC (SNGX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SNGX.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-31 | 1 | $6 | $6 | $6 | $0.907 | 561.52% |
2022-08-18 | 1 | $4 | $4 | $4 | $0.907 | 341.01% |
Price Target Last Issued March 31, 2022
The Trend in the Analyst Price Target
Over the past 14 months, SNGX's average price target has gone up $0.19.
500 - Internal server error
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|
SNGX Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
SNGX's average broker recommendation rating worsened by 0.5 over the prior 43 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SOLIGENIX INC's number of analysts covering the stock is greater than just about none of of all US stocks.
- SNGX has a lower variance in analysts' estimates than nearly 100% of all US stocks.
- SNGX has a greater average analyst price target than 13.22% of Healthcare stocks.
- In the context of Healthcare stocks, SOLIGENIX INC's upside potential (average analyst target price relative to current price) is greater than 158.98% of them.
Stocks similar to SOLIGENIX INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ADTX, IPA, and GANX.
View All Top Stocks by Price Target
Is SNGX a Buy, Hold or Sell? See the POWR Ratings now!